Back to top

Oppenheimer Reinstates Mind Medicine (MNMD) with Outperform Rating | MNMD Stock News

Oppenheimer Reinstates Mind Medicine (MNMD) with Outperform Rating | MNMD Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Mind Medicine (MindMed) Inc. (MNMD)